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Eukaryotic translation termination is triggered
by peptide release factors eRF1 and eRF3.
Whereas eRF1 recognizes all three termination
codons and induces hydrolysis of peptidyl
tRNA, eRF3’s function remains obscure. Here,
we reconstituted all steps of eukaryotic transla-
tion in vitro using purified ribosomal subunits;
initiation, elongation, and termination factors;
and aminoacyl tRNAs. This allowed us to inves-
tigate termination using pretermination com-
plexes assembled on mRNA encoding a tetra-
peptide and to propose a model for translation
termination that accounts for the cooperative
action of eRF1 and eRF3 in ensuring fast release
of nascent polypeptide. In this model, binding of
eRF1, eRF3, and GTP to pretermination com-
plexes first induces a structural rearrangement
that is manifested as a 2 nucleotide forward
shift of the toeprint attributed to pretermination
complexes that leads to GTP hydrolysis fol-
lowed by rapid hydrolysis of peptidyl tRNA. Co-
operativity between eRF1 and eRF3 required
the eRF3 binding C-terminal domain of eRF1.
INTRODUCTION
The final step in protein synthesis, hydrolysis of the ester
bond of the peptidyl tRNA and release of the nascent poly-
peptide, occurs when one of three termination codons
(UAA, UGA, or UAG) in mRNA reaches the ribosomal A
site. Hydrolysis of thepeptidyl-tRNAester bond in the pep-
tidyl transferase center (PTC) in the large ribosomal sub-
unit depends on two classes of release factors (RFs) (Kis-
selev et al., 2003; Nakamura and Ito, 2003). Prokaryotic
(RF1 and RF2) and eukaryotic (eRF1) class 1 RFs directly
recognize termination codons in the A site on the smallribosomal subunit and stimulate peptide release in the PTC
of the large subunit; the mechanism of signal transduction
between subunits is not known. RF1 recognizes UAA and
UAG codons, and RF2 recognizes UAA and UGA codons,
whereas eukaryotic eRF1 recognizes all three stop co-
dons. Human eRF1 consists of N, M, and C domains
(Song et al., 2000), which correlate with its three different
functions. Conserved NIKS and YxCxxxF motifs in the N
domain are implicated in stop-codon recognition (Cha-
vatte et al., 2002; Frolova et al., 2002; Ito et al., 2002;
Seit-Nebi et al., 2002; Kolosov et al., 2005). Stop codons
are recognized at the decoding center in the small subunit
by eRF1 itself rather than by elements of the ribosome
(Kervestin et al., 2001). The tip of the M domain contains
a GGQ motif that is common to all class 1 RFs and is re-
quired to trigger peptidyl-tRNA hydrolysis in eukaryotes
(Frolova et al., 1999; Song et al., 2000) and prokaryotes
(Mora et al., 2003; Zavialov et al., 2002). The RF2GGQmo-
tif most likely mimics the CCA end of tRNA and occupies
the sameposition in theA site (Petry et al., 2005). TheCdo-
main mediates eRF1’s interaction with class 2 RFs (see
below).
Class 2 RFs are represented by a single protein in pro-
karyotes (RF3) and two proteins in mammals (eRF3a and
eRF3b) (reviewed by Kisselev and Buckingham, 2000; Kis-
selev et al., 2003). RF3 and eRF3 both contain GTP bind-
ing domains that share homology, whereas other regions
of these factors are not homologous. eRF3 is essential,
whereas RF3 is not (reviewed by Kisselev and Bucking-
ham, 2000). RF3 does not accelerate the rate of binding
of RF1/RF2 to pretermination complexes (pre-TCs) with
peptidyl tRNA in the P site and a termination codon in
the A site, nor does it affect the catalytic rate constant
for hydrolysis of peptidyl tRNA (reviewed by Zavialov
et al., 2001). Instead, it mediates recycling of RF1/RF2
from posttermination complexes (Zavialov et al., 2001,
2002). Although the role of RF3 is now well understood,
that of eRF3 remains obscure. The ribosome-dependent
GTPase activity of RF3 is stimulated by RF1/RF2 in a
codon-dependent manner (Zavialov et al., 2001), where-
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GTPaseactivity is codon independent (Frolovaet al., 1996).
A distinguishing feature of eRF3 is its ability to forma stable
complex with eRF1 (Frolova et al., 1998; Stansfield et al.,
1995; Zhouravleva et al., 1995) through mutual binding of
their C-terminal domains (Ito et al., 1998; Ebihara and
Nakamura, 1999; Merkulova et al., 1999). Roles that have
been proposed for eRF1 in enhancing eRF3’s GTPase
activity include acting as a guanine nucleotide exchange
factor or a GTPase-activating protein (Frolova et al., 1996).
It has been suggested that eRF3 might perform a role
similar to that of prokaryotic RF3 by promoting recycling
of eRF1 (Zavialov et al., 2001), but recent genetic data
suggest that eRF3’s GTPase activity might instead couple
termination-codon recognition by eRF1 with efficient
peptide release (Salas-Marco and Bedwell, 2004).
The principal assay used for many years to study termi-
nation in vitro is based on artificial pre-TCs obtained by
binding an AUG initiation codon and a stop signal
(UAAA, UAGA, or UGAA) to ‘‘empty’’ ribosomes reconsti-
tuted from 40S and 60S subunits in the presence of
[35S]fMet-tRNA to simulate peptidyl tRNA (Caskey et al.,
1974). Release of [35S]fMet from fMet-tRNA mimics pep-
tidyl-tRNA hydrolysis. This assay has several major limita-
tions. First, fMet-tRNA is an inadequate model for peptidyl
tRNA because open reading frames in natural mRNAs en-
code at least 2 to 3 amino acids, and simultaneous occu-
pation of P and A sites by initiation and stop codons never
occurs in natural mRNAs. Second, this assay employs
separated initiation and stop codons instead of a continu-
ous mRNA. These limitations therefore preclude using this
assay to investigate ribosome translocation at the termi-
nation step, ribosomal recycling, the influence of the pep-
tidyl moiety on termination efficiency, potential coupling
between termination and initiation, etc.
Recent progress in understanding intermediate steps in
translation in bacteria has been achievedmainly due to the
possibility of reconstituting the bacterial protein-synthe-
sizingmachinery in vitro from individual components. In vi-
tro reconstruction of the eukaryotic translation apparatus
from individual components is a priori more difficult owing
to its greater complexity, particularly at the initiation stage.
However, eukaryotic initiation (Pestova et al., 1998, 2000)
and elongation (Pestova and Hellen, 2003) steps have
been reconstituted in vitro, so that reconstitution of termi-
nation, and thus of the entire eukaryotic translation pro-
cess, has become feasible.
We report here that we have reconstituted eukaryotic
translation initiation, elongation, and termination pro-
cesses in vitro on a model mRNA encoding a tetrapeptide
followed by a UAA stop codon using individual 40S and
60S ribosomal subunits and the complete set of individual
initiation (eIF), elongation (eEF), and release factors. This
allowed us to assay the individual roles of eRF1 and
eRF3 in a system that closely resembles the physiological
termination process and, as a result, to propose an exper-
imentally based model for the mechanism of translation
termination in eukaryotes. Binding of eRF1, eRF3, and
GTP to the ribosomal pre-TC induces a structural rear-1126 Cell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc.rangement that is characterized by a 2 nucleotide (2 nt)
forward shift of the toeprint attributed to the pre-TC and
is independent of GTP hydrolysis. Subsequent GTP hy-
drolysis is required for rapid hydrolysis of peptidyl tRNA
in the pre-TC. Cooperativity between eRF1 and eRF3 in
ensuring fast peptidyl-tRNA hydrolysis requires the eRF3
binding C-terminal domain (CTD) of eRF1.
RESULTS
Assembly of Ribosomal Pretermination Complexes
Ribosomal pre-TCs were assembled on MVHL-STOP
mRNA (Figure 1A) containing 12 unstructured 50-terminal
nucleotides (four CAA triplets) followed by the b-globin
50 untranslated region (UTR), nucleotides encoding the
tetrapeptide MVHL followed by a UAA stop codon, and
an400 nt 30UTR comprising the rest of the natural b-glo-
bin coding sequence. In toeprinting experiments, 48S
complexes formed efficiently on the AUG triplet of this
mRNA in the presence of 40S subunits; eIFs 1, 1A, 2, 3,
4A, 4B, and 4F; and Met-tRNAMeti (Figure 1B, lane 2). In
the presence of 40S and 60S subunits; eIFs 1, 1A, 2, 3,
4A, 4B, 4F, 5, and 5B; eEF1H and eEF2; and total tRNA
aminoacylated with Met, Val, His, and Leu, pre-TCs with
the CUG leucine codon in the P site and the UAA stop co-
don in the A site formed efficiently and yielded a character-
istic toeprint 16 nt downstream of the C of the CUG leucine
codon (Figure 1B, lane 3). Pre-TCs were stable and could
be separated by sucrose density gradient centrifugation
(Figure 1D, lane 1) from unbound translation components
and from eIFs that may have remained weakly associated
with ribosomes after translation of this short open reading
frame (Po¨yry et al., 2004). Purification of pre-TCs in this
way allowed the activity of RFs to be investigated in the
absence of eIFs and eEFs. We determined that commer-
cial total tRNA contained substantially less tRNAHis than
tRNAMeti, tRNA
Val, and tRNALeu. By lowering the amount
of total aminoacylated tRNA in reaction mixtures so that
the concentration of tRNAHis (but not tRNAVal and tRNALeu)
was lower than that of translating ribosomes, wewere able
to obtain a large quantity of elongation complexes with
a valine GUG codon and base-paired Met-Val-tRNAVal in
the P site and a histidine CAU codon (which could not
be decoded) in the A site (Figure 1C, lane 1). Such com-
plexes were used as internal negative controls for the
specificity of action of RFs.
GTP Hydrolysis by eRF3 Is Required for Its
Stimulation of Peptide Release by eRF1
We used recombinant human eRF3C lacking the N-termi-
nal 138 amino acids that are dispensable for eRF3’s
GTPase activity and for its stimulation of eRF1 release ac-
tivity (Frolova et al., 1998), recombinant human eRF1, and
two eRF1 mutants: eRF1(AGQ) with a G183A mutation in
the GGQ motif that can bind ribosomes and stimulate
eRF3’s GTPase activity but is inactive in peptide release
(Frolova et al., 1999) and eRF1(NM) that lacks the eRF3
binding CTD but is active in triggering peptidyl-tRNA
Figure 1. Formation of Pre-TCs on MVHL-STOP mRNA
(A) The structure of the 50UTR and coding region of MVHL-STOP mRNA, with its initiation and stop codons shown in bold.
(B–D) Toeprinting analysis of initiation, elongation, and pretermination complexes assembled on MVHL-STOP mRNA. Reaction mixtures contained
translation components as indicated. Before toeprinting, the reactionmixture used for the experiment shown in (C) was subjected to sucrose gradient
centrifugation. The positions of ribosomal complexes are shown relative to the mRNA codon in the ribosomal P site. Full-length cDNA is labeled in (B).
Lanes C, T, A, and G show the cDNA sequence corresponding to MVHL-STOP mRNA derived using the same primer as was used for toeprinting.hydrolysis (Frolova et al., 1999, 2000). To investigate the
activities of eRF1 and eRF3 in peptide release, pre-TCs
assembled on MVHL-STOP mRNA in the presence of
[35S]Met-tRNAMeti were incubated with saturating
amounts of eRF1, eRF1(AGQ), eRF1(NM), and eRF3C in-
dividually or in various combinations in the presence of
GTP, GDP, or the nonhydrolyzable GTP analog GMPPNP
or in the absence of guanine nucleotides. Release of
[35S]Met-Val-His-Leu tetrapeptide wasmonitored by scin-
tillation counting of supernatants after TCA precipitation of
reaction mixtures (Figure 2A). Incubation of the pre-TCs
with eRF1 alone or together with eRF3C in the presence
of GTP or GDP or in the absence of guanine nucleotides
resulted in nearly complete peptide release. However, in
the presence of GMPPNP, eRF3C completely inhibited
peptide release by eRF1. eRF1(NM) alone was as active
as eRF1, but its activity was not inhibited by the simulta-
neous presence of eRF3C and GMPPNP. As expected,
neither eRF3C nor eRF1(AGQ) individually or together
caused peptide release.
The specificity of peptide release by eRF1 and eRF3
was confirmed byHPLC analysis. The amount of total ami-
noacylated tRNA in reaction mixtures was reduced to ob-
tain a relatively large quantity of elongation complexes
containing tRNA linked to a MV dipeptide in addition to
pre-TCs containing tRNA linked to the MVHL tetrapeptide
(Figure 1C). Reaction mixtures were then incubated witheRF1, eRF3C, and GTP or were subjected to alkaline hy-
drolysis, and resulting peptides were analyzed by HPLC.
Whereas similar quantities of di- and tetrapeptides were
detected after alkaline hydrolysis, only the expected tetra-
peptide was obtained after incubation with eRF1, eRF3C,
and GTP (Figure 2B). This result confirmed that eRF1 and
eRF3 mediated peptide release exclusively from pre-TCs
assembled on the stop codon.
In experiments shown in Figure 2A, the prolonged time
of incubation and the high concentration of eRF1 allowed
nearly complete peptide release by it alone. Therefore, ki-
netic experiments with reduced concentrations of RFs
were done to investigate eRF3C’s influence on peptide re-
lease by eRF1 (Figures 2C and 2D). Whereas in the pres-
ence of eRF1, peptide release was slow (Figure 2C) and
did not depend on the presence of guanine nucleotides
(data not shown), eRF1 with eRF3C cooperatively pro-
moted fast peptide release in the presence of GTP
(Figure 2C). Peptide release was weakly enhanced by
eRF3 and GDP. However, the kinetics of peptide release
in the presence of GDP spiked with trace amounts of
GTP (to mimic possible low-level GTP contamination of
commercial GDP preparations) suggested that such con-
tamination probably accounted for the observed en-
hancement. eRF3C did not enhance peptide release in
the absence of guanine nucleotides (Figure 2C). Peptide
release promoted by eRF1 occurred at as fast a rate inCell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc. 1127
Figure 2. Peptide Release from the Pre-TC in the Presence of Different Combinations of eRF1, eRF3C, and Various Guanine
Nucleotides and Stimulation of eRF3’s GTPase Activity by 80S Ribosome and eRF1
(A) Release of [35S]MVHL tetrapeptide from pre-TCs after their incubation for 20 min with combinations of saturating amounts of eRF1 and eRF3C in
the presence of guanine nucleotides, as indicated, or in the absence of RFs (background). Data are presented as mean ± SD of three independent
experiments.
(B) HPLC analysis of peptides released from ribosomal complexes after alkaline hydrolysis or incubation with eRF1, eRF3C, and GTP.
(C) Kinetics of [35S]MVHL tetrapeptide release in the presence of eRF1 (black triangles); eRF1 and eRF3 (blue stars); eRF1, eRF3C, and GDP (green
circles); or eRF1, eRF3C, and GTP (red squares) and in the absence of eRFs (black circles).
(D) Kinetics of [35S]MVHL release in the presence of eRF1(NM) (black triangles) or eRF1(NM), eRF3C, andGTP (red squares) and in the absence of RFs
(black circles).
(E) Thin-layer chromatography analysis of the stimulation of eRF3 GTPase activity by 80S ribosomes and eRF1. Positions of [32P]GTP and [32P]Pi are
indicated.1128 Cell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc.
the presence of eRF3 with dGTP as with GTP (Supple-
mental Data). Peptide release in the presence of
eRF1(NM) alone was slow, similar to peptide release
with eRF1 alone (Figures 2C and 2D) but was not stimu-
lated by eRF3/GTP (Figure 2D). Consistent with previous
reports (Frolova et al., 1999, 2000), eRF1(NM) did not stim-
ulate eRF3’s GTPase activity in the presence of 80S ribo-
somes, in contrast to eRF1 and eRF1(AGQ) (Figure 2E).
In conclusion, eRF3C strongly stimulated peptide re-
lease by eRF1 in the presence of GTP and completely
inhibited it in the presence of GMPPNP. Cooperativity in
peptide release in the presence of GTP, its inhibition in
the presence of GMPPNP, as well as stimulation of
eRF3’s GTPase activity by eRF1 all required the eRF3
binding CTD of eRF1.
Structural Rearrangement of Pretermination
Complexes by eRF1 and eRF3
The influence of eRF1 and eRF3C on the pre-TC in the
presence of GTP or GMPPNP was also investigated by
toeprinting analysis (Figure 3). Ribosomal complexes
were again assembled with reduced amounts of total ami-
noacylated tRNA to form a relatively high proportion of
‘‘negative control’’ elongation complexes with the histi-
dine CAU codon in the A site. The concentrations of
eRF1 and eRF3C and the duration of their incubation
with pre-TCs were the same as in Figure 2A, where
eRF1 alone mediated complete peptide release.
In the presence of GTP, incubation of pre-TCs with
eRF1 alone led only to a reduction in the intensity of their
characteristic toeprint 16 nt downstream of the P site leu-
cine CUG codon (Figure 3A, lane 2). Incubation with eRF1
and eRF3C together also substantially reduced this toe-
print’s intensity and shifted the toeprint attributed to pre-
TCs forward by 2 nt to a position 15 nt downstream of
the UAA stop codon (Figure 3A, lane 3). Incubation of
pre-TCs with only eRF1(AGQ) (which is inactive in peptide
release) partially shifted the pre-TC toeprint without re-
ducing its overall intensity (Figure 3A, lane 4), whereas in-
cubation with eRF1(AGQ), eRF3C, and GTP shifted it for-
ward almost quantitatively (Figure 3A, lane 5). The toeprint
shift therefore did not require peptide release. Incubation
with eRF1(NM) alone or with eRF3 reduced only the inten-
sity but not the position of the toeprint (Figure 3A, lanes 6
and 7). The eRF1 CTD was therefore required for the
eRF3-dependent toeprint shift. Incubation with eRF3C
alone did not influence the intensity or the position of the
toeprint attributable to pre-TCs (Figure 3A, lane 10). A sim-
ilar shift of the toeprint of 80S ribosomal complexes as-
sembled on an mRNA containing the cricket paralysis vi-
rus internal ribosomal entry site followed immediately by
a stop codon occurred in the presence of eRF1 and elon-
gation factor eEF2 (Jan et al., 2003). Althoughwe could re-
produce these results on a similar mRNA (data not shown),
eEF2 alone influenced neither the intensity nor the position
of the toeprint corresponding to pre-TCs formed on
MVHL-STOP mRNA (Figure 3A, lane 8) and, with eRF1,caused the same reduction in its intensity as eRF1 alone,
without changing its position (Figure 3A, lane 9).
As in the presence of GTP, incubation of the pre-TCwith
eRF1 alone in the presence of GMPPNP only reduced the
intensity of the toeprint 16 nt downstream from the leucine
CUG codon, and incubation with eRF3C did not alter ei-
ther the toeprint intensity or position (Figure 3B, lanes 2
and 3). However, incubation with eRF1 and eRF3C in the
presence of GMPPNP did not reduce the intensity of the
pre-TC toeprint as occurred in the presence of GTP
(Figure 3A, lane 3) but instead quantitatively shifted it to
a position 15 nt downstream of the UAA stop codon (Fig-
ure 3B, lane 4), just as when the pre-TC was incubated
with eRF1(AGQ), eRF3C, and GTP (Figure 3A, lane 5).
The toeprint shift therefore required neither peptide re-
lease nor GTP hydrolysis by eRF3C. In the presence of
GMPPNP, incubation with eRF1(NM) alone or with
eRF3C led only to a reduction in the intensity of the toe-
print 16 nt downstream from the leucine CUG codon
(Figure 3B, lanes 5 and 6), as in the presence of GTP. In
all experiments, eRF1 and eRF3 specifically influenced
the toeprint attributed to pre-TCswith theUAA stop codon
in the A site and had no effect on toeprints attributed to
other elongation complexes (Figure 3A, lanes 2–10;
Figure 3B, lanes 2–6). Interestingly, addition of eEF2 alone
or together with eRF1 or eRF3C in the presence of
GMPPNP caused a nonspecific 1 nt reverse shift in the
toeprints of all elongation complexes (Figure 3B, lanes
7–9), which could be explained by conformational
changes in them caused by binding of eEF2/GMPPNP to
80S ribosomes (Spahn et al., 2004). Moreover, the shift
in the pre-TC toeprint caused by the simultaneous pres-
ence of eRF3C and eRF1 or eRF1(AGQ) was reduced by
eEF2 (Figure 3B, compare lanes 10 and 11 with lane 4).
eEF2 and eRF3 likely compete for binding to the 80S ribo-
some since the G domains of eEF2 and eRF3 almost cer-
tainly bind to overlapping ribosomal areas. Inclusion of
eEF2 in reaction mixtures containing eRF1(NM) and
eRF3C did not cause the toeprint of the pre-TC to shift
to the position 15 nt downstream from the UAA codon
but again caused a nonspecific reverse shift in the toe-
prints of all elongation complexes (Figure 3B, lane 12).
The reduced intensity of toeprints corresponding to pre-
TCs in those reaction mixtures in which peptide release
was permitted (Figure 3A, lanes 2, 3, 6, 7, and 9;
Figure 3B, lanes 2, 5, and 6) could be due to either their
spontaneous dissociation or their lower stability during re-
verse transcription reactions.
We observed that peptide release was stimulated by
eRF3C in the presence of dGTP and that the toeprint of
pre-TCs assembled on MVHL-STOP mRNA shifted after
incubation with eRF1, eRF3C, and dGTP even at the
high Mg2+ concentration required for toeprinting (Supple-
mental Data). These observations indicate that the toe-
print shift on MVHL-STOP mRNA would always have the
chance to occur during the reverse transcription stage
even if it had not occurred during earlier incubation. To
exclude the influence of dGTP on the toeprint shift,Cell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc. 1129
Figure 3. Translocation/Structural Rearrangement of the Pre-TC by eRF1 and eRF3
(A and B) Toeprinting analysis of pre-TCs formed on MVHL-STOP mRNA after incubation with different combinations of eRF1, eRF3C, and eEF2, as
indicated, in the presence of (A) GTP or (B) GMPPNP.
(C) Toeprinting analysis of pre-TCs formed on MVHL-STOP/C-less mRNA after incubation with eRF1, eRF3C, and guanine nucleotides, as indicated.
The positions of ribosomal complexes are shown on the right. Lanes C, T, A, and G depict cDNA sequences corresponding to MVHL-STOP and
MVHL-STOP/C-less mRNAs, as appropriate, derived using the toeprinting primer.MVHL-STOP/C-less mRNA was used that lacked cyti-
dines between the stop codon and the primer for reverse
transcription and thus did not need dGTP for toeprinting.
Analysis of pre-TCs assembled on MVHL-STOP/C-less
mRNA indicated that the toeprint shift occurred after their
incubation with eRF1 and eRF3C only in the presence of1130 Cell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc.GTPorGMPPNP (Figure 3C, lanes 2 and 3). In the presence
of GDP or the absence of guanine nucleotides, incubation
of pre-TCs with eRF1 and eRF3C weakened the toeprint
without altering its position (Figure 3C, lanes 4 and 5), ex-
actly as was observed after incubating them with eRF1
alone (Figures 3A and 3B, lanes 2). This result indicated
that the presence of guanine triphosphates is mandatory
for the toeprint shift.
In conclusion, we found that eRF1 and eRF3C together,
or, to some extent, eRF1(AGQ) alone, shifted the pre-TC
toeprint forward by 2 nt to a position 15 nt downstream
of the stop codon. The observed toeprint shift occurred
in the presence of GMPPNP or eRF1(AGQ) and was there-
fore independent of GTP hydrolysis and peptide release.
However, in the case of eRF3C and eRF1, it required the
eRF3 binding CTD of eRF1. This shift could either reflect
a major structural rearrangement of the termination com-
plex or be a consequence of translocation of peptidyl
tRNA (or at least of its anticodon arm) and the P site codon
in the direction of the E site and simultaneous movement
of the UAA stop codon toward the P site.
Evidence that Rearrangement of the Pretermination
Complex Precedes Peptide Release
After noting that eRF1 and eRF3C cause rearrangement of
the pre-TC, we determined whether the acceptor arm of
peptidyl tRNA in such complexes was still properly posi-
tioned in the PTC of the 60S subunit by investigating the
activity of rearranged termination complexes in the pep-
tidyl-puromycin synthesis reaction. Pre-TCs were assem-
bled on MVHL-STOP mRNA using [3H]Leu-tRNALeu,
which allowed the activity of only those complexes that
contained a P site tRNA linked to Met-Val-His-[3H]Leu tet-
rapeptide to be monitored. Pre-TCs were then incubated
with eRF1, eRF3C, and GMPPNP, with eRF1(AGQ),
eRF3C, and GTP or with eRF1(AGQ), eRF3C, and
GMPPNP to allow rearrangement to occur in conditions
that do not permit peptidyl-tRNA hydrolysis but either do
or do not permit GTP hydrolysis by eRF3C. In control ex-
periments, pre-TCs were incubated either with eRF1,
eRF3C, and GTP to allow efficient peptide release or
with buffer lacking RFs. All reaction mixtures were divided
into two parts, one of which was then incubated with pu-
romycin. Finally, both peptide release and peptidyl-puro-
mycin synthesis were assayed in all reaction mixtures
(Figure 4A). As expected, without incubation with puromy-
cin, peptide release occurred only after treatment of
pre-TCs with eRF1, eRF3C, and GTP. Determination of
peptide release and peptidyl-puromycin synthesis after in-
cubation of ribosomal complexes with puromycin showed
that rearranged termination complexes formed in the
presence of eRF1, eRF3C, and GMPPNP; eRF1(AGQ),
eRF3C, and GTP; or eRF1(AGQ), eRF3C, and GMPPNP
were as reactive with puromycin as pre-TCs that had not
been treated with RFs. As expected, peptidyl puromycin
was not formed in a control reaction containing com-
plexes that had been incubated with eRF1, eRF3C, and
GTP. These results indicate that the aminoacylated 30
CCA end of peptidyl tRNA in rearranged complexes is still
properly positioned in the ribosomal PTC and can partici-
pate in a reaction that mimics peptide bond formation.
We also determined the effect of puromycin treatment
on rearranged ribosomal complexes using the toeprinting
assay (Figure 4B). Incubation with puromycin of rear-ranged complexes formed in the presence of eRF1(AGQ),
eRF3C, and GTP; eRF1(AGQ), eRF3C, and GMPPNP; or
eRF1, eRF3, and GMPPNP (Figure 4B, lanes 2, 3, and 6)
strongly reduced the corresponding toeprint (Figure 4B,
lanes 8, 9, and 12), just as when pre-TCs were treated
with eRF1, eRF3C, and GTP (Figure 4B, lane 5). This could
be due to their spontaneous dissociation or to their re-
duced stability during reverse transcription. Dissociation
of rearranged complexes formed in the presence of
GMPPNP was slightly lower than that of complexes
formed with GTP (Figure 4B, compare lanes 9, 12, and
8). Although the mechanism and order of dissociation of
eRF1 and eRF3C from termination complexes is unknown,
eRF3C may bind more stably to ribosomal complexes in
the presence of GMPPNP, which in turn might influence
their stability. Treatment of pre-TCs with eRF1 alone or
with puromycin (Figure 4B, lanes 4 and 7) resulted in lower
dissociation of pre-TCs than in reactions that also con-
tained eRF3C (Figure 4B, lanes 5, 8, and 11). This indi-
cates that peptide release from pre-TCs without their rear-
rangement yields complexes that are more stable than
those obtained after peptide release from rearranged
complexes. It is possible that one of the functions of rear-
rangement of the pre-TC is to prepare ribosomal com-
plexes for the next stage of ribosomal recycling.
In conclusion, the fact that the 30 CCA end of peptidyl
tRNA in rearranged pre-TCs remains properly positioned
in the PTC of the 60S subunit suggests that rearrangement
of pre-TCs likely precedes peptide release.
DISCUSSION
Complete reconstitution of the translation process in vitro
enabled the functions of both RFs to be investigated using
a pre-TC formed on a continuous mRNA with a tetrapep-
tidyl tRNA in the P site and a UAA stop codon in the A site
instead of the only previously available artificial model pre-
TC described in the Introduction. This advance allowed us
to assay the individual roles of eRF1 and eRF3 and to pro-
pose a model for termination in which binding of eRF1,
eRF3, and GTP to the pre-TC induces a major structural
rearrangement that leads to GTP hydrolysis followed by
rapid release of the nascent peptide.
eRF1, eRF3, and GTP Act Cooperatively to Ensure
Fast Peptidyl-tRNA Hydrolysis in the Pretermination
Complex
Peptide release from pre-TCs in the presence of eRF1
alone was slow but became fast when eRF1, eRF3C,
and GTP were present together (Figure 2C). In these ex-
periments, the concentration of eRF1 was 10-fold higher
than of pre-TCs, so that quantitative peptide release did
not require recycling of eRF1. Stimulation of peptide re-
lease by eRF3C in the presence of GTP, as well as its com-
plete inhibition by eRF3C with GMPPNP, could therefore
not be explained by its hypothetical function in recycling
eRF1 (Zavialov et al., 2001). This suggests that eRF3 and
GTP could stimulate peptide release by increasing eitherCell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc. 1131
Figure 4. Puromycin-Dependent Peptide Release from Translocated/Rearranged Pre-TCs
(A) Release of M-V-H-[3H]L tetrapeptide (white columns) and M-V-H-[3H]L-puromycin synthesis (gray columns) after incubation with puromycin of
translocated/rearranged pre-TCs formed in the presence of eRF1, eRF3, and GMPPNP; eRF1(AGQ), eRF3C, and GTP; or eRF1(AGQ), eRF3C,
and GMPPNP as indicated. Control reactions include untreated pre-TCs (background) and pre-TCs incubated with eRF1, eRF3C, and GTP. Data
are presented as mean ± SD of three independent experiments.
(B) Toeprinting analysis of the influence of incubation with puromycin on translocated/rearranged pre-TCs formed onMVHL-STOPmRNA in the pres-
ence of eRF1, eRF3C, and GMPPNP; eRF1(AGQ), eRF3C, and GTP; or eRF1(AGQ), eRF3C, and GMPPNP, as indicated. Control reactions include
untreated pre-TCs and pre-TCs incubated with eRF1 alone or with eRF1, eRF3C, and GTP. Positions of ribosomal complexes and full-length cDNA
are indicated.1132 Cell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc.
the catalytic rate of peptide release and/or the affinity of
eRF1 to the pre-TC, particularly taking into account that
the eRF3-interacting CTD of eRF1 was required for stimu-
lation of peptide release by eRF3 (Figures 2C and 2D). A 2-
to 3-fold reduction in steady-state levels of eRF3 in vivo
was recently reported to decrease termination efficiency
but not to reduce ribosomal association of eRF1 (Salas-
Marco and Bedwell, 2004). These observations suggest
that association of eRF1 with eRF3 is not required to de-
liver eRF1 to ribosomes. However, the observed stimula-
tion of peptide release by eRF3C in a simplifiedmodel sys-
tem at low stop-codon concentrations (Zhouravleva et al.,
1995) would support the role of eRF3 in increasing the af-
finity of eRF1 to the pre-TC. Recent data showing that as-
sociation of yeast eRF1 and eRF3 is GTP dependent at
physiological Mg2+ concentrations (Kobayashi et al.,
2004) are also consistent with a proposal that eRF1 could
bind to pre-TCs as a ternary complex with eRF3/GTP (Na-
kamura et al., 1996). In this case, stimulation by eRF3 and
GTP of peptide release would at least in part be due to in-
creased affinity of eRF1 to the pre-TC. However, kinetic
studies to distinguish between eRF3 stimulating peptide
release by increasing either the catalytic rate of peptide re-
lease or the affinity of eRF1 to the pre-TC (or both) were
outside the scope of the present investigation, so this
question remains open.
Binding of eRF1, eRF3, and GTP to the
Pretermination Complex Induces a Large Structural
Rearrangement that Does Not Require GTP
Hydrolysis or Release of the Nascent Peptide
Binding of eRF1, eRF3C, and GTP to the pre-TC induced
a major structural rearrangement characterized by a 2 nt
forward shift of the toeprint attributed to the pre-TC to
a position +15 nt downstream of the first nucleotide of
the UAA stop codon (Figure 3). This rearrangement re-
quired the eRF3 binding CTD of eRF1 but did not depend
on hydrolysis of GTP or peptidyl tRNA. The shifted toeprint
is consistent with translocation of the P site codon and at
least the anticodon stem loop of peptidyl tRNA toward the
E site and of the stop codon from the A site toward the P
site. Toeprints are conventionally +16 rather than +15 nt
downstream of the first nucleotide of the P site codon,
so the +15 toeprint raises questions about the complete-
ness of the hypothetical translocation. However, we note
that +15 nt toeprints are not uncommon in eukaryotes,
particularly in initiation complexes. The possibility that
the toeprint shift reflects translocation of only mRNA but
not P site tRNA is unlikely because it would require disrup-
tion of interactions of both the codon and anticodon in the
P site and of eRF1 with the stop codon in the A site. Alter-
natively, the toeprint shift could reflect a structural rear-
rangement of the pre-TC that does not involve movement
ofmRNA along the 40S subunit. Thus, association of yeast
80S ribosomes with sordarin bound eEF2, which has sim-
ilarities to the GTPase activation state of eEF2, results in
a ratchet-like subunit rearrangement that also includes ro-
tational movement of the head of the 40S subunit that af-fects its noncovalent interaction with the body, particularly
in the region of the mRNA entry channel (Spahn et al.,
2004). Such structural changes of the 40S subunit in the
region of the mRNA entry channel might affect the extent
to which reverse transcriptase can penetrate into ribo-
somal complexes during toeprinting and consequently
cause the toeprint shift even if rearrangement of ribosomal
complexes does not involve translocational mRNA move-
ment along the 40S subunit. In fact, we did observe a 1 nt
toeprint shift upon binding of eEF2-GMPPNP to elonga-
tion complexes (Figure 3). Potential structural changes in
the mRNA entry-channel region of the 40S subunit that
could occur upon binding of eRF1 and eRF3-GTP to pre-
TCs could also cause the toeprint shift even if rearrange-
ment of the pre-TCs does not involve mRNA movement.
Further experiments to determine the position of mRNA
in pre- and post-TCs (e.g., by site-directed UV crosslink-
ing of mRNA with ribosomal components) are required to
discriminate between these alternatives and, if rearrange-
ment does involve translocation, to determine its extent.
Even if binding of eRF1, eRF3C, andGTP induces trans-
location of the pre-TC, the acceptor end of peptidyl
tRNA remains properly positioned in the PTC of the 60S
subunit because rearranged complexes formed with
eRF1/eRF3C/GMPPNP or eRF1(AGQ)/eRF3C/GTP (which
were not competent in peptide release) both efficiently
supported peptidyl-puromycin synthesis (Figure 4). The
fact that puromycin could bind productively to the A site
of rearranged complexes formed with eRF1/eRF3/
GMPPNP also indicates that the GGQ motif of eRF1 is
not properly placed in the PTC until after hydrolysis of
eRF3 bound GTP. Importantly, although the toeprint shift
did not occur with eRF1 alone, it occurred in the presence
of eRF1(AGQ) alone (Figure 3A), albeit with lower effi-
ciency than with both eRF1 and eRF3C. This indicates
that eRF1 can induce pre-TC rearrangement even in the
absence of eRF3C, but only if the structure of the GGQ
loop is altered. It is therefore likely that interaction of
eRF1, eRF3, and GTP on or even off the ribosome results
in a conformational change in eRF1, particularly in the
GGQ loop region, which allows structural rearrangement
of the pre-TC but temporarily inhibits eRF1’s ability to in-
duce peptide release until eRF3 bound GTP is hydrolyzed.
Hydrolysis of eRF3 bound GTP could either result in eRF3
release from ribosomes or alter its interaction with eRF1,
which in turn would alter the conformation/position of
the GGQ loop and its fitting into the PTC of the 60S sub-
unit. This model provides a mechanism for coupling GTP
hydrolysis with subsequent release of the nascent pep-
tide. The observation that eRF1 alone did not mediate re-
arrangement of the pre-TC but could induce peptide re-
lease (albeit inefficiently) accounts for the functionality of
the standard termination assay (Caskey et al., 1974).
Termination of Translation in Eukaryotes: A Model
and Comparison with Prokaryotes
Data reported here lead us to propose amodel for termina-
tion in eukaryotes (Figure 5). Step 1 is binding of eRF1,Cell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc. 1133
Figure 5. A Model for Translation Termination in Eukaryotes
Step 1: Binding of eRF1, eRF3, and GTP to the pre-TC. Step 2: Pre-TC translocation/structural rearrangement. Step 3: GTP hydrolysis by eRF3.
Step 4: Peptidyl-tRNA hydrolysis and peptide release.eRF3, and GTP to the pre-TC. The order and form (i.e.,
GTP or GDP bound) in which these factors bind to the
pre-TC is not known, but the possibility that they bind as
a preformed eRF1eRF3GTP ternary complex (see
above) is attractive. Binding of eRF1, eRF3, and GTP to
the pre-TC leads to its rearrangement (step 2), which could
be either amajor structural change or a partial or complete
translocation of the P site codon and anticodon arm (but
not the acceptor arm) of peptidyl tRNA toward the E site
and of the A site stop codon toward the P site. The GGQ
motif of eRF1 is not properly positioned in the PTC of the
rearranged complex, and this requires GTP hydrolysis by
eRF3 (step 3). Hydrolysis of eRF3 bound GTP could either
result in release of eRF3-GDP from ribosomes or alter its
interaction with eRF1, which allows correct fitting of the
GGQ motif in the PTC. In step 4, properly positioned
eRF1 finally triggers hydrolysis of peptidyl tRNA. The
next step, which was not investigated here, would be dis-
sociation of either eRF1 and eRF3 or eRF1 alone, if eRF3-
GDP had been released immediately after GTP hydrolysis.
Steps 3 and 4 in our model are consistent with a recent
model based on genetic data, according to which hydroly-
sis of GTP by eRF3 is required for peptide release by eRF1
(Salas-Marco and Bedwell, 2004).
These genetic data and our biochemical data imply that
prokaryotic RF3 and eukaryotic eRF3 play different roles
during termination. Whereas RF3 increases the rate of
RF1/RF2 release from the ribosome (Zavialov et al.,
2001), eRF3 ensures rapid and efficient hydrolysis of pep-
tidyl tRNA. Consequently, one of the most striking differ-
ences in the two termination processes is that in prokary-
otes, peptide release precedes and is required for GTP
hydrolysis, whereas in eukaryotes, GTP hydrolysis by
eRF3 is required to permit subsequent hydrolysis of pep-
tidyl tRNA. This mechanistic difference raises the question
of why peptide release in eukaryotes occurs by a more
complicated mechanism that requires an active role of
eRF3. Such a mechanism could, as suggested (Salas-
Marco and Bedwell, 2004), increase the fidelity of eukary-
otic termination, which relies on a single eRF1 for recogni-
tion of all three stop codons, which may occur with lower
selectivity than by the two prokaryotic class 1 RFs. The
presumably less selective binding of eRF1 to near-cog-
nate codons might not lead to peptide release either be-
cause such pre-TCs would dissociate during rearrange-1134 Cell 125, 1125–1136, June 16, 2006 ª2006 Elsevier Inc.ment (step 2) or because they would be unable to
activate GTP hydrolysis by eRF3. Another likely reason
is that the next stage in translation, ribosomal recycling,
might occur by different mechanisms in prokaryotes and
eukaryotes. The observed rearrangement of pre-TCs
upon binding eRF1, eRF3, and GTPmight weaken associ-
ation of ribosomal subunits and their binding with deacy-
lated tRNA, and, if the rearrangement involves transloca-
tion of pre-TCs, deacylated tRNA might even be bound
to the E instead of the P site (as in prokaryotes), from
which it could dissociate more easily or even spontane-
ously. Such a rearrangement stage might play a prepara-
tory role for ribosomal recycling by weakening the result-
ing post-TC and thus could account for the absence of
a ribosomal recycling factor (RRF) in eukaryotes and ex-
plain why eRF3 has evolved so that it is indispensable
whereas RF3 is not.
EXPERIMENTAL PROCEDURES
Plasmids
Expression vectors for His6-tagged eIFs 1, 1A, 4A, 4B, and 5 (Pestova
et al., 1996, 1998, 2000); eRF1; eRF1(AGQ) mutant; and eRF3aC lack-
ing the N-terminal 138 aa (Frolova et al.,1998, 1999, 2002) have been
described. pET-eRF1(NM) for expression of a His6-tagged eRF1 frag-
ment corresponding to the N and M domains was made by inserting
a PCR fragment derived from pERF4B (Frolova et al., 2002) between
the NdeI and XhoI sites of pET23b (Novagen). The MVHL-STOP tran-
scription vector was made by inserting a PCR fragment derived from
b-globin cDNA using a forward primer that contained a T7 promoter
sequence, four CAA repeats, and nt 1–21 of the b-globin 50UTR and
a reverse primer that was complementary to the stop codon and the
last 17 nt of the b-globin coding region between BglII and XhoI sites
of pET28a. Subsequent PCRmutagenesis altered the 5th coding triplet
to a UAA termination codon and the downstreamUGUGU sequence to
AGUGA. The MVHL-STOP/C-less transcription vector (made by Gen-
Script Corp.) contained a T7 promoter; four CAA repeats; the 50UTR of
b-globin mRNA; and Met, Val, His, and Leu codons, followed by a UAA
stop codon; 80 randomized A, T, and G nt (AAGTGAGTATTGAGTT
AGTTTAATATAGGAGTAGAGTAGGTTTAGATAGAGTGGATAGTAATA
TAGAGAGTTGTTATAGT); and b-globin nt 197–214, inserted between
PstI and BamHI sites of pUC57. ThemRNAs were transcribed using T7
polymerase. The MVHL-STOP vector was digested with MscI a few nt
upstream of the native stop codon of b-globin mRNA. The MVHL-
STOP/C-less vector was linearized with BamHI.
Purification of Factors and Ribosomal Subunits
Rabbit 40S and 60S subunits; eIFs 2, 3, 4F, and 5B; eEF1H; and eEF2
were purified as described (Pestova et al., 1996, 2000; Pestova and
Hellen, 2003). His6-tagged eIFs 1, 1A, 4A, 4B, and 5; eRF1;
eRF1(AGQ); eRF1(NM); and eRF3C were expressed in E. coli
BL21(DE3) and purified as described (Frolova et al., 1994, 1998,
2000; Pestova et al., 1996, 1998, 2000).
Aminoacylation of tRNA
Rabbit aminoacyl-tRNA synthetases were purified and native total
tRNA (Novagen) was aminoacylated with Met, Val, His, and Leu in
the presence of [35S]Met or [3H]Leu as described (Pestova and Hellen,
2003). The specific activities of [35S]Met-tRNAMet and [3H]Leu-tRNALeu
were 210,000 and 160,000 cpm/pmol, respectively.
Pretermination Complex Assembly and Purification
48S complexes were assembled by incubating 3 mg MVHL-STOP
mRNA in a 400 ml reaction mixture that contained buffer A (20 mM
Tris [pH 7.5], 100 mM KAc, 2.5 mM MgCl2, 2 mM DTT, 400 U RNasin)
supplemented with 1 mM ATP, 0.25 mM spermidine and 0.2 mM GTP,
150 or 75 mg total tRNA (aminoacylatedwith Val, His, 35S-labeled or un-
labeled Met, and 3H-labeled or unlabeled Leu), 30 pmol 40S subunits,
100 pmol eIF2, 100 pmol eIF3, 100 pmol eIF4F, 120 pmol eIF4A, 120
pmol eIF4B, 300 pmol eIF1, and 300 pmol eIF1A for 15 min at 37ºC
and then incubated for 15 min with 200 pmol eIF5, 70 pmol eIF5B,
and 35 pmol 60S subunits to form 80S complexes. Pre-TCs were ob-
tained by incubating 80S complexes with 100 pmol eEF1H and 100
pmol eEF2 for 15 min and then purified by centrifugation in a Beckman
SW55 rotor for 1 hr 35 min at 4ºC and 50,000 rpm in 10%–30% linear
sucrose density gradients prepared in buffer A with 5mMMgCl2. Frac-
tions that corresponded to pre-TCs by optical density and the pres-
ence of [35S]Met or [3H]Leu were combined, diluted 3-fold with buffer
A containing 1.25 mM MgCl2 (to a final concentration of 2.5 mM
Mg2+), and used to assay peptide release or peptidyl-puromycin syn-
thesis or for toeprinting.
Peptide Release Assay
For experiments described in Figure 2A, 70 ml aliquots containing 0.12
pmol of pre-TCs (25,000 cpm) assembled with [35S]Met-tRNA were in-
cubated at 37ºC for 20min with excess (20 pmol) eRF1 or mutant eRF1
and eRF3C either individually or in different combinations in the pres-
ence of 1 mMGTP, GDP, or GMPPNP or in the absence of guanine nu-
cleotides. To ensure that free Mg2+ concentrations were identical in all
reaction mixtures, 1 mM MgCl2 was added to those that contained
1 mM guanine nucleotides. Peptide release was assayed by TCA pre-
cipitation as described (Zavialov et al., 2001). For kinetic experiments
(Figures 2C and 2D), the amount of eRF1 and eRFC3 in reaction mix-
tures was reduced to 1 pmol per 50 ml probe. Four hundred and thirty
microliter aliquots of pre-TCs were preincubated at 37ºC for 5 min,
after which peptide release was initiated by addition of eRF1 alone
or with eRF3C, and 50 ml aliquots were taken at different times.
HPLC Analysis of Released Peptides
To obtain a relatively large quantity of elongation complexes contain-
ing tRNA linked to a MV dipeptide, pre-TCs were assembled with a re-
duced amount of tRNA aminoacylated in the presence of [35S]Met.
One hundred and twenty microliters of pre-TCs (65,000 c.p.m.) was ei-
ther incubated with 70 pmol eRF1 and 10 pmol eRF3C in the presence
of 1mMGTPor subjected to alkaline hydrolysis by incubatingwith 0.2M
NaOH for 15 min at 37ºC. After addition of 200 mg of an equimolar
mixture of MV, MVH, and MVHL di-, tri-, and tetrapeptides (Biopeptide
Co., Inc.) to a reaction probe containing pre-TCs incubated with eRF1
and eRF3C and addition of 5 ml ice-cold acetic acid and 200 mg of the
same mixture of peptides to a reaction probe containing pre-TCs that
had been subjected to alkaline hydrolysis, both probes were centri-
fuged at 14,000 3 g for 5 min, and supernatants were subjected to
centrifugation through YM-10 microcons at 14,000 3 g for 20 min.
Both flowthrough fractions were applied to a 4.6 3 250 mm C18
reverse-phase column (Vydac). Bound peptides were eluted witha 0%–32% acetonitrile gradient containing 0.1% TFA. Optical density
(OD220) and radioactivity were measured across gradients.
eRF3 GTPase Assay
0.8 pmol 40S subunits, 0.8 pmol 60S subunits, 5 pmol eRF1 or
eRF1(AGQ), or eRF1(NM) and 5 pmol eRF3C in different combinations
were incubated in 20 ml buffer A containing 2 mM GTP (with 20 mCi
[g-32P]GTP) at 37ºC for 20 min. Two microliter aliquots were spotted
onto polyethyleneimine-cellulose plates for chromatography done us-
ing 0.8M LiCl/0.8 M acetic acid. eRF3 GTPase activity was assayed by
formation of [32P]Pi.
Toeprinting Analysis of Pretermination Complexes
Sixty microliter aliquots of pre-TCs were incubated with 10 pmol eRF1,
eRF1(AGQ), eRF1(NM), and eRF3C in different combinations in the
presence of 1 mM GTP or GMPPNP for 15 min at 37ºC and analyzed
by primer extension as described (Pestova et al., 1996). Toeprinting
analysis was done in the presence of [a-32P]dATP using a primer com-
plementary to nt 197–214 of b-globin mRNA. cDNA products were an-
alyzed by electrophoresis through 6% polyacrylamide sequencing gel
and subsequent autoradiography.
Puromycin Reaction by Rearranged Pretermination Complexes
Peptide Release and Peptidyl-Puromycin Synthesis Assays
One hundred and fifty microliter aliquots (20,000 cpm) of pre-TCs as-
sembled in the presence of [3H]Leu-tRNALeu were incubated with 30
pmol eRF1, eRF1(AGQ), and eRF3C in different combinations in the
presence of 1 mM GTP or GMPPNP for 15 min at 37ºC to obtain rear-
ranged pre-TCs, which were then incubated with 1 mM puromycin for
15minmore. All reactionmixtures were divided into two parts. The first
part was used to determine peptide release by TCA precipitation as
described above, whereas the second was processed as described
(Pestova et al., 2000) to assay peptidyl-puromycin synthesis.
Toeprint Analysis
Rearranged pre-TCs incubated with 1 mM puromycin were analyzed
by primer extension as described above.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and one figure and can be found with this article online at http://
www.cell.com/cgi/content/full/125/6/1125/DC1/.
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